China · Delayed Price · Currency is CNY Hangzhou Biotest Biotech Statistics
Total Valuation
SHA:688767 has a market cap or net worth of CNY 5.70 billion. The enterprise value is 4.54 billion.
| Market Cap | 5.70B |
| Enterprise Value | 4.54B |
Important Dates
The last earnings date was Saturday, August 29, 2026.
| Earnings Date | Aug 29, 2026 |
| Ex-Dividend Date | Jun 1, 2026 |
Share Statistics
SHA:688767 has 146.32 million shares outstanding. The number of shares has decreased by -16.91% in one year.
| Current Share Class | 146.32M |
| Shares Outstanding | 146.32M |
| Shares Change (YoY) | -16.91% |
| Shares Change (QoQ) | +6.38% |
| Owned by Insiders (%) | 24.48% |
| Owned by Institutions (%) | 8.64% |
| Float | 56.78M |
Valuation Ratios
The trailing PE ratio is 255.90.
| PE Ratio | 255.90 |
| Forward PE | n/a |
| PS Ratio | 12.41 |
| PB Ratio | 2.66 |
| P/TBV Ratio | 3.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 84.32 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 223.59 |
| EV / Sales | 9.88 |
| EV / EBITDA | 110.10 |
| EV / EBIT | 269.51 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.51, with a Debt / Equity ratio of 0.05.
| Current Ratio | 9.51 |
| Quick Ratio | 8.96 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 2.43 |
| Debt / FCF | -1.37 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.86% and return on invested capital (ROIC) is 1.74%.
| Return on Equity (ROE) | 0.86% |
| Return on Assets (ROA) | 0.43% |
| Return on Invested Capital (ROIC) | 1.74% |
| Return on Capital Employed (ROCE) | 0.75% |
| Weighted Average Cost of Capital (WACC) | 7.71% |
| Revenue Per Employee | 749,454 |
| Profits Per Employee | 33,113 |
| Employee Count | 613 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 3.58 |
Taxes
| Income Tax | -5.78M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.64% in the last 52 weeks. The beta is 0.65, so SHA:688767's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -0.64% |
| 50-Day Moving Average | 37.05 |
| 200-Day Moving Average | 37.83 |
| Relative Strength Index (RSI) | 52.58 |
| Average Volume (20 Days) | 2,439,573 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688767 had revenue of CNY 459.42 million and earned 20.30 million in profits. Earnings per share was 0.15.
| Revenue | 459.42M |
| Gross Profit | 207.12M |
| Operating Income | 16.84M |
| Pretax Income | 13.51M |
| Net Income | 20.30M |
| EBITDA | 41.22M |
| EBIT | 16.84M |
| Earnings Per Share (EPS) | 0.15 |
Balance Sheet
The company has 1.26 billion in cash and 100.18 million in debt, with a net cash position of 1.16 billion or 7.96 per share.
| Cash & Cash Equivalents | 1.26B |
| Total Debt | 100.18M |
| Net Cash | 1.16B |
| Net Cash Per Share | 7.96 |
| Equity (Book Value) | 2.14B |
| Book Value Per Share | 13.80 |
| Working Capital | 1.29B |
Cash Flow
In the last 12 months, operating cash flow was 67.59 million and capital expenditures -140.90 million, giving a free cash flow of -73.31 million.
| Operating Cash Flow | 67.59M |
| Capital Expenditures | -140.90M |
| Depreciation & Amortization | 24.38M |
| Net Borrowing | 99.73M |
| Free Cash Flow | -73.31M |
| FCF Per Share | -0.50 |
Margins
Gross margin is 45.08%, with operating and profit margins of 3.67% and 4.42%.
| Gross Margin | 45.08% |
| Operating Margin | 3.67% |
| Pretax Margin | 2.94% |
| Profit Margin | 4.42% |
| EBITDA Margin | 8.97% |
| EBIT Margin | 3.67% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 1.67%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 1.67% |
| Dividend Growth (YoY) | -48.42% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 515.67% |
| Buyback Yield | 16.91% |
| Shareholder Yield | 18.58% |
| Earnings Yield | 0.36% |
| FCF Yield | -1.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 6, 2025. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 6, 2025 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |